Growth Metrics

Solid Biosciences (SLDB) Other Non Operating Income (2017 - 2024)

Historic Other Non Operating Income for Solid Biosciences (SLDB) over the last 7 years, with Q4 2024 value amounting to $199000.0.

  • Solid Biosciences' Other Non Operating Income fell 2629.63% to $199000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $652000.0, marking a year-over-year decrease of 4045.66%. This contributed to the annual value of $652000.0 for FY2024, which is 4045.66% down from last year.
  • As of Q4 2024, Solid Biosciences' Other Non Operating Income stood at $199000.0, which was down 2629.63% from $211000.0 recorded in Q3 2024.
  • Solid Biosciences' Other Non Operating Income's 5-year high stood at $282000.0 during Q1 2023, with a 5-year trough of -$355000.0 in Q4 2022.
  • Moreover, its 4-year median value for Other Non Operating Income was $205000.0 (2024), whereas its average is $114750.0.
  • As far as peak fluctuations go, Solid Biosciences' Other Non Operating Income crashed by 9952.83% in 2020, and later skyrocketed by 893333.33% in 2023.
  • Over the past 4 years, Solid Biosciences' Other Non Operating Income (Quarter) stood at $1000.0 in 2020, then tumbled by 35600.0% to -$355000.0 in 2022, then soared by 176.06% to $270000.0 in 2023, then dropped by 26.3% to $199000.0 in 2024.
  • Its Other Non Operating Income stands at $199000.0 for Q4 2024, versus $211000.0 for Q3 2024 and $239000.0 for Q2 2024.